IX Biopharma News

General Announcement-Press Release - iXB 401 Achieves 20x Higher Bioavailability Than Rybelsus in Preclinical Study

Nov 19 17:46

General Announcement-Minutes of Extraordinary General Meeting Held on 17 October 2024

Nov 15 18:00

General Announcement-Minutes of Annual General Meeting Held on 17 October 2024

Nov 15 17:57

General Announcement-Formation of the Audit and Risk Committee and Reconstitution of the Board Committees

Oct 17 19:06

IX Biopharma: REPL-Extraordinary/ Special General Meeting-Voluntary

Oct 17 19:00

IX Biopharma: REPL-Annual General Meeting-Voluntary

Oct 17 18:53

General Announcement-Press Release - iX Biopharma Appoints Dr. Brian Kennedy as New Scientific Advisor

Oct 14 17:39

IX Biopharma: Extraordinary/ Special General Meeting-Voluntary

Oct 1 06:49

Change - Announcement of Cessation-Retirement of Independent Director

Oct 1 06:45

IX Biopharma: Annual General Meeting-Voluntary

Oct 1 06:41

General Announcement-Press Release - Business and Drug Development Updates - Wafermine and iXB 401

Sep 16 17:37

General Announcement-Press Release - New Study Demonstrates that SL-NAD+ Delivers NAD+ into Cells

Sep 2 07:12

General Announcement-Press Release - New Study Highlights CBD Wafer's Potential in Kidney Failure Patients

Aug 12 18:50

REPL-General Announcement-Issue and Listing of the Rights Shares and the Warrants

Jul 22 17:39

General Announcement-Issue and Listing of the Rights Shares and the Warrants

Jul 19 18:16

IX Biopharma: General Announcement-Notice From Undertaking Shareholder Anson Properties Pte. Ltd.

Jul 15 17:44

IX Biopharma: General Announcement-Press Release - Breakthrough Sublingual Wafers Raise NAD+ Levels, Enhance Well-Being in Human Trial

Jul 9 18:57

IX Biopharma: General Announcement-Proposed Renounceable Non-Underwritten Rights Cum Warrants Issue-Despatch of Notification and Forms

Jul 1 17:55

IX Biopharma: General Announcement-Notice of Adjustment to Conversion Price of 9% Convertible Bonds Principal Amount S$2 Million

Jun 18 17:56

IX Biopharma: General Announcement-Update For Shareholders

Mar 20 18:51